XML 61 R50.htm IDEA: XBRL DOCUMENT v3.20.2
Grant Revenue (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Dec. 31, 2019
Oct. 31, 2017
May 31, 2017
Jun. 30, 2016
May 31, 2016
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Grant Revenue                  
Revenue           $ 593,165 $ 342,487 $ 1,495,045 $ 1,043,549
Pelican Therapeutics, Inc.                  
Grant Revenue                  
Amount awarded from CPRIT grant         $ 15,200,000        
Remaining grant amount           1,500,000   1,500,000  
Contribution to be made by Pelican           7,600,000   $ 7,600,000  
Pelican Therapeutics, Inc. | Maximum                  
Grant Revenue                  
Amount awarded from CPRIT grant       $ 15,200,000          
Royalty percentage after threshold is met               1.00%  
Pelican Therapeutics, Inc. | Tranche I                  
Grant Revenue                  
Revenue     $ 1,800,000            
Pelican Therapeutics, Inc. | Tranche II                  
Grant Revenue                  
Revenue   $ 6,500,000              
Pelican Therapeutics, Inc. | Tranche III                  
Grant Revenue                  
Revenue $ 5,400,000                
Pelican Therapeutics, Inc. | Grant revenue                  
Grant Revenue                  
Revenue               $ 11,800,000  
Amount the company is required to match of each dollar of grant           0.50   0.50  
Threshold amount for match of grant           $ 1.00   $ 1.00